RxFiles

What RxFiles does

RxFiles is a non-profit academic detailing program and drug information publisher operating within the University of Saskatchewan's College of Pharmacy and Nutrition in Saskatoon, Canada. Founded in 1997 by pharmacist Loren Regier, it produces objective, evidence-based drug comparison resources for physicians, pharmacists, and other prescribers, explicitly refusing funding from the pharmaceutical industry to preserve editorial independence.

Its core products are the RxFiles Drug Comparison Charts (currently 15th Edition, 135 charts and 240+ pages, published August 2025) and Geri-RxFiles (4th Edition, ~250 pages covering medication assessment in older adults, published May 2024). These are delivered through a web platform at rxfiles.ca, an iOS mobile app (RxFiles PLUS), and hardcopy book sales, complemented by newsletters, Q&A documents, trial summaries (e.g., CLARITY AD, FLOW, FIDELIO-DKD), and clinical tools such as asthma action plans and patient booklets. The platform is essentially a curated content library rather than a software product.

RxFiles generates revenue through three streams: Saskatchewan Ministry of Health government funding for the academic detailing service, individual subscriptions ($135/year or $239 for two years), and one-time book and clinical-tool sales (15th Edition $150, Geri-RxFiles 4th Edition $90, combo $195). Its go-to-market combines a sales-led academic detailing motion (one-on-one in-person/virtual visits to Saskatchewan prescribers in 15-60 minute sessions) with a self-serve direct-to-consumer subscription channel via website and mobile app, plus partnerships with the Saskatchewan Health Authority and healthcare organizations for group access.

Name

RxFiles

Legal name

RxFiles Academic Detailing

Website

https://rxfiles.ca

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

RxFiles is a University of Saskatchewan-based non-profit that publishes objective, pharma-industry-independent drug comparison charts and academic detailing services for physicians, pharmacists, and prescribers across Canada.

Ownership category

akta.pro rank

Product category

Pharmacy Information Resources

NAICS

Other Scientific and Technical Consulting Services (541690)

SIC

Services-Health Services (8000)

akta.pro primary industry

Real-World Data (RWD) / Real-World Evidence (RWE) & Observational Research Platforms (HLACAOAM)

Keywords

• Drug comparison charts
• Academic detailing service
• Pharmacy information resources
• Clinical decision support
• Evidence-based prescribing

Headquarters

HQ city

Saskatoon

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Subscription Revenue: Annual and biennial subscriptions provide access to the online platform and mobile app, including drug comparison charts, newsletters, Q&As, and trial summaries. Subscriptions are available at $135 for 1 year and $239 for 2 years.
2. Book Sales: Sale of hardcopy Drug Comparison Charts (15th Edition at $150) and Geri-RxFiles (4th Edition at $90), with combo deals available at $195. Individual patient booklets sold at $2.99 each, with bundles of 60 booklets at $45.
3. Government Funding: Funding received from the Saskatchewan Ministry of Health to support the academic detailing program and drug information services.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Core offering

RxFiles is an academic detailing program operated out of the University of Saskatchewan that develops and disseminates evidence-based drug information resources for healthcare professionals. It produces drug comparison charts, geriatric prescribing references, an online subscription service (RxFiles PLUS), and patient education booklets, while also providing in-person and virtual academic detailing visits to physicians, pharmacists, and healthcare organizations.

Product overview

RxFiles is an academic detailing program at the University of Saskatchewan that provides objective, comparative drug information to healthcare clinicians. The core product is the RxFiles Drug Comparison Charts (now in its 15th Edition), a comprehensive book of 135 drug comparison charts with over 240 pages of evidence-based content. This is complemented by Geri-RxFiles (4th Edition), a specialized guide for medication assessment in older adults with ~250 pages. The portfolio also includes RxFiles PLUS subscriptions for online and mobile app access, newsletters covering topics like ADHD/COPD/Kidney Health, Q&A documents, Trial Summaries of landmark clinical studies, and practical Clinical Tools including patient booklets, prescription pads, and action plans for conditions such as asthma and COPD. The organization does not accept pharmaceutical industry funding, relying instead on Saskatchewan Ministry of Health funding and product sales. An iOS mobile app provides on-the-go access to subscribers.

Differentiator

Problem solved

Functional benefit

Brands

• RxFiles PLUS: Online subscription and app access to RxFiles resources including Drug Comparison Charts and Geri-RxFiles Charts.
• RxFiles Drug Comparison Charts
• Geri-RxFiles

Products and services

• RxFiles Drug Comparison Charts (15th Edition) Printed and digital reference book providing side-by-side, evidence-based comparisons of drug therapies across therapeutic categories, used by prescribers, pharmacists, and other healthcare professionals.
• Geri-RxFiles (4th Edition) Specialized drug comparison reference tailored to prescribing considerations in older adults, including dosing, renal/hepatic adjustments, and adverse effect considerations in the elderly.
• RxFiles PLUS Subscription Annual online subscription that gives healthcare professionals access to the full library of RxFiles drug comparison charts, Q&As, trial summaries, and continually updated clinical tools.
• Academic Detailing Service One-on-one or small-group educational visits by trained pharmacists to physicians and other prescribers, delivering unbiased, evidence-based information on specific drug therapy topics.
• Patient Booklets Bundle Curated bundle of plain-language patient education booklets designed to support counselling by healthcare professionals on common medication-related topics.

Quantifiable outcome

• One-on-one interactive discussions with physicians at their practice site shown to be one of the most successful methods to support and improve therapeutic decision making

Named customers3 records

Segments1 record

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• University of Saskatchewan - College of Pharmacy and NutritioncoreStrategic or Co-development PartnerRxFiles Academic Detailing is part of the University of Saskatchewan, based out of the Health Sciences' College of Pharmacy and Nutrition since 2018. Provides academic affiliation and institutional support.
• Saskatchewan Health AuthoritycoreStrategic or Co-development PartnerMany RxFiles team members work jointly with the Saskatchewan Health Authority. The academic detailing service is available to healthcare providers within the SHA system.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• UpToDate (Wolters Kluwer): UpToDate is the dominant subscription-based clinical decision-support resource used by physicians worldwide, including across Canada. It overlaps with RxFiles in delivering evidence-based drug therapy guidance, but is a broad, continually updated resource serving all of medicine rather than a drug-comparison specialist.
• First Databank (FDB): First Databank provides drug knowledge bases and medication decision-support that integrate into EHR and pharmacy systems. It is comparable to RxFiles as a drug information content provider but operates at the infrastructure/EHR-embedded layer rather than as a direct clinician-facing subscription.
• Lexicomp (Wolters Kluwer): Lexicomp is a widely used commercial drug information and clinical decision-support resource for pharmacists and prescribers. It competes with RxFiles Drug Comparison Charts on core drug comparison functionality but is integrated into pharmacy information systems and hospital EHRs rather than delivered as standalone book/app subscriptions.
• DynaMed (EBSCO): DynaMed is a leading point-of-care clinical reference tool competing with UpToDate in the physician decision-support space. It overlaps with RxFiles in providing evidence-based drug information to prescribers, but offers continuously updated content across all therapeutic areas rather than focused drug comparisons.

Direct peers

• NaRCAD (National Resource Center for Academic Detailing): NaRCAD is the leading US academic detailing training and support organization that works with public health agencies and clinical programs to deliver evidence-based prescribing outreach. It functions as both a peer in methodology and a potential channel for scaling RxFiles' model internationally.
• Centre for Effective Practice (CEP): CEP is a Canadian organization that develops evidence-based tools and resources for primary care providers, and its clinical pharmacist Margaret Jin has partnered with RxFiles since 2006. It is comparable as a fellow Canadian evidence-based clinical resource developer serving primary care prescribers.
• Alosa Health: Alosa Health is a US-based academic detailing organization that delivers evidence-based drug information directly to prescribers through field-based outreach. It shares RxFiles' core academic detailing methodology and pharma-free funding model, making it the most operationally similar peer outside Canada.
• Canadian Agency for Drugs and Technologies in Health (CADTH): CADTH is Canada's federal/provincial health technology assessment agency that produces independent, evidence-based drug reviews and recommendations. Like RxFiles, it serves Canadian healthcare providers with objective drug information not funded by the pharmaceutical industry, and is the closest Canadian institutional peer in mission and content type.

Emerging players

• PEER (Patient Evidence-Based Emergency department Research) / Tools for Practice: PEER/Tools for Practice is a Canadian initiative producing concise, evidence-based clinical reviews for primary care, distributed through the Alberta College of Family Physicians. It overlaps with RxFiles' Q&A and trial summary products as succinct evidence synopses for clinicians, but is organized around question-driven reviews rather than drug comparison charts.

Regional players

• Therapeutic Guidelines (eTG complete): Therapeutic Guidelines is an Australian non-profit producer of independent, evidence-based treatment guidelines used by clinicians. It shares RxFiles' non-commercial funding model and mission of supporting evidence-based prescribing, but operates in a different geography and as comprehensive therapeutic guidelines rather than drug comparison charts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC1YsYNQPxgkSr3U8xJts9JA
• LinkedInlinkedin.com/company/rxfiles

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RxFiles